Nucleic acid vaccines against malaria.
Doolan
Denise L
DL
Malaria Program, Naval Medical Research Center, Silver Spring, Md., USA.
Hoffman
Stephen L
SL
D000276:Adjuvants, Immunologic; D000818:Animals; D000953:Antigens, Protozoan / Q000276:immunology; D001029:Aotus trivirgatus; D017321:Clinical Trials, Phase I as Topic; D003062:Codon / Q000235:genetics; D015195:Drug Design; D005069:Evaluation Studies as Topic; D018503:Genome, Protozoan; D014943:Global Health; D006801:Humans; D007111:Immunity, Cellular; D007114:Immunization; D007117:Immunization, Secondary; D008288:Malaria / Q000517:prevention & control* / Q000662:veterinary; D017780:Malaria Vaccines / Q000276:immunology; D051379:Mice; D023421:Models, Animal; D010961:Plasmodium / Q000254:growth & development / Q000276:immunology*; D010963:Plasmodium falciparum / Q000235:genetics / Q000276:immunology; D015800:Protozoan Proteins / Q000276:immunology; D012449:Safety; D019444:Vaccines, DNA
D000276:Adjuvants, Immunologic; D000953:Antigens, Protozoan; D003062:Codon; D017780:Malaria Vaccines; D015800:Protozoan Proteins; D019444:Vaccines, DNA